Bill
SB 1473
AN ACT REQUIRING MEDICAID COVERAGE FOR FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.
2025 Regular Session
Introduced by Saud Anwar and 9 co-sponsors
Connecticut requires Medicaid coverage of FDA-approved gene therapies for sickle cell disease, removing prior authorization requirements to expand patient access to potentially curative treatments.
SIGNED BY GOVERNOR